Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions
出版年份 2020 全文链接
标题
Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions
作者
关键词
-
出版物
Cancers
Volume 12, Issue 8, Pages 2057
出版商
MDPI AG
发表日期
2020-07-27
DOI
10.3390/cancers12082057
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
- (2020) Camilla U. Persson et al. EXPERIMENTAL CELL RESEARCH
- Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression
- (2020) Shweta Joshi et al. MOLECULAR CANCER THERAPEUTICS
- Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress
- (2020) Juanjuan Zhao et al. ANNALS OF HEMATOLOGY
- Eradication of neuroblastoma by T cells redirected with an optimized GD2-specific chimeric antigen receptor and interleukin-15
- (2019) Yuhui Chen et al. CLINICAL CANCER RESEARCH
- NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors
- (2019) Robin Parihar et al. Cancer Immunology Research
- Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
- (2019) Shweta Joshi et al. Journal of Oncology
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer
- (2019) Shweta Joshi et al. MOLECULAR CANCER THERAPEUTICS
- Diversity, Mechanisms, and Significance of Macrophage Plasticity
- (2019) Massimo Locati et al. Annual Review of Pathology-Mechanisms of Disease
- Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation
- (2019) Patrizia Murer et al. New Biotechnology
- Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2
- (2019) Sascha Troschke-Meurer et al. OncoImmunology
- Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
- (2019) Julie Voeller et al. Journal for ImmunoTherapy of Cancer
- Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes
- (2018) Matthew W. Webb et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Presentation, Evaluation, and Management of Neuroblastoma
- (2018) Richa Sharma et al. PEDIATRICS IN REVIEW
- Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo
- (2018) Theresa Relation et al. STEM CELLS
- Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
- (2018) Thitinee Vanichapol et al. Biomed Research International
- Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
- (2018) Sundary Sormendi et al. Frontiers in Immunology
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Safety, PK/PD, and anti-tumor activity of RO6874281, an engineered variant of interleukin-2 (IL-2v) targeted to tumor-associated fibroblasts via binding to fibroblast activation protein (FAP).
- (2018) Morten Mau Soerensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells
- (2018) Gloria Pelizzo et al. BMC CANCER
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- CAR T Cell Therapy for Neuroblastoma
- (2018) Rebecca M. Richards et al. Frontiers in Immunology
- Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
- (2018) Takefumi Komiya et al. Frontiers in Oncology
- Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation
- (2017) Robert H. Scannevin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study
- (2017) Shakeel Modak et al. PEDIATRIC BLOOD & CANCER
- Dual-activity PI3K–BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis
- (2017) Forest H. Andrews et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma
- (2017) Wen-Guang He et al. Oncotarget
- A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models
- (2017) Binbing Ling et al. Oncotarget
- Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC
- (2017) Michael D. Hadjidaniel et al. Oncotarget
- High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
- (2017) Sarah A. Richman et al. Cancer Immunology Research
- The MYCN Protein in Health and Disease
- (2017) María Victoria Ruiz-Pérez et al. Genes
- Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model
- (2017) Paola Bocca et al. OncoImmunology
- VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma
- (2017) Wen-Chin Weng et al. Scientific Reports
- Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
- (2016) Irene Tadeo et al. BRITISH JOURNAL OF CANCER
- More than the genes, the tumor microenvironment in neuroblastoma
- (2016) Lucia Borriello et al. CANCER LETTERS
- A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
- (2016) Eli M. Wallace et al. CANCER RESEARCH
- Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
- (2016) Y. Mao et al. CLINICAL CANCER RESEARCH
- Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development
- (2016) Okito Hashimoto et al. JOURNAL OF PATHOLOGY
- Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma
- (2016) A. R. Singh et al. MOLECULAR CANCER THERAPEUTICS
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
- (2016) Caroline Jochems et al. Oncotarget
- Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors
- (2016) Lynsey Vaughan et al. Oncotarget
- Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126
- (2016) Anat Erdreich-Epstein et al. Oncotarget
- Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients
- (2016) Mark A. Applebaum et al. Oncotarget
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis
- (2016) Su Yin Lim et al. Oncotarget
- Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
- (2016) Francesca Cammarota et al. Stem Cells International
- Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
- (2016) A. H. Long et al. Cancer Immunology Research
- CD4+CD25hiCD127− Treg and CD4+CD45R0+CD49b+LAG3+ Tr1 cells in bone marrow and peripheral blood samples from children with neuroblastoma
- (2016) Fabio Morandi et al. OncoImmunology
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies
- (2015) Naomi D’souza et al. BMC Medicine
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma
- (2015) Shweta Joshi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis
- (2015) Josephine H. HaDuong et al. INTERNATIONAL JOURNAL OF CANCER
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- IL-10 and ARG-1 Concentrations in Bone Marrow and Peripheral Blood of Metastatic Neuroblastoma Patients Do Not Associate with Clinical Outcome
- (2015) Fabio Morandi et al. Journal of Immunology Research
- Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
- (2015) Marco Mina et al. OncoImmunology
- Mesenchymal Stromal Cell Secretome Up-Regulates 47 kDa CXCR4 Expression, and Induce Invasiveness in Neuroblastoma Cell Lines
- (2015) Vipin Shankar et al. PLoS One
- Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCNlow Neuroblastoma
- (2015) Shanique A. Young et al. PLoS One
- Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in 12 V-Ha-Ras transgenic mouse glioma model
- (2014) Alok R Singh et al. Cancer Cell International
- Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity
- (2014) Valentina Rigo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- MDM2 Regulates Hypoxic Hypoxia-inducible Factor 1α Stability in an E3 Ligase, Proteasome, and PTEN-Phosphatidylinositol 3-Kinase-AKT-dependent Manner
- (2014) Shweta Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Macrophage-Dominant PI3K Isoform Controls Hypoxia-Induced HIF1α and HIF2α Stability and Tumor Growth, Angiogenesis, and Metastasis
- (2014) Shweta Joshi et al. MOLECULAR CANCER RESEARCH
- Circulating T-Regulatory Cells in Neuroblastoma: A Pilot Prospective Study
- (2014) TVSVGK Tilak et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo
- (2014) Shweta Joshi et al. PLoS One
- GD2-Targeted Immunotherapy and Radioimmunotherapy
- (2014) Konstantin Dobrenkov et al. SEMINARS IN ONCOLOGY
- Tumor Dynamics in Response to Antiangiogenic Therapy with Oral Metronomic Topotecan and Pazopanib in Neuroblastoma Xenografts
- (2014) Sushil Kumar et al. Translational Oncology
- ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
- (2014) G Bianchi et al. Cell Death & Disease
- Enhanced differentiation of human neural crest stem cells towards the Schwann cell lineage by aligned electrospun fiber matrix
- (2013) Yong-Juan Ren et al. Acta Biomaterialia
- Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models
- (2013) G. Cassinelli et al. BIOCHEMICAL PHARMACOLOGY
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma
- (2013) Tasnim Ara et al. CANCER RESEARCH
- Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma
- (2013) Lena-Maria Carlson et al. CARCINOGENESIS
- Hypoxia-inducible factor 1α in breast cancer prognosis
- (2013) Wei Wang et al. CLINICA CHIMICA ACTA
- Polyphenol E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells
- (2013) G. Santilli et al. CLINICAL CANCER RESEARCH
- B cells and their mediators as targets for therapy in solid tumors
- (2013) Andrew J. Gunderson et al. EXPERIMENTAL CELL RESEARCH
- Allosteric inhibition of hypoxia inducible factor-2 with small molecules
- (2013) Thomas H Scheuermann et al. Nature Chemical Biology
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Efficacy and toxicity of plerixafor for peripheral blood stem cell mobilization in children with high-risk neuroblastoma
- (2013) Meong Hi Son et al. PEDIATRIC BLOOD & CANCER
- Tumor and its microenvironment: A synergistic interplay
- (2013) Veronica Catalano et al. SEMINARS IN CANCER BIOLOGY
- Tumor-associated macrophages: functional diversity, clinical significance, and open questions
- (2013) Subhra K. Biswas et al. Seminars in Immunopathology
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Neuroblastoma-related inflammation
- (2013) Lena-Maria Carlson et al. OncoImmunology
- Immunosuppressive Microenvironment in Neuroblastoma
- (2013) Vito Pistoia et al. Frontiers in Oncology
- Changing the Tumor Microenvironment: New Strategies for Immunotherapy
- (2012) P. Berraondo et al. CANCER RESEARCH
- Glycosaminoglycans: from “cellular glue” to novel therapeutical agents
- (2012) Nikos K Karamanos et al. CURRENT OPINION IN PHARMACOLOGY
- Glycosaminoglycans: key players in cancer cell biology and treatment
- (2012) Nikos Afratis et al. FEBS Journal
- VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours
- (2012) Pramila Ramani et al. HISTOPATHOLOGY
- HIF-1α up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas
- (2012) Josiah V Dungwa et al. HISTOPATHOLOGY
- Cancer-associated fibroblasts as targets for immunotherapy
- (2012) Sunitha Kakarla et al. Immunotherapy
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Rationale Behind Targeting Fibroblast Activation Protein-Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy
- (2012) W. N. Brennen et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha
- (2012) H Zhang et al. ONCOGENE
- Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
- (2012) Julie Liberman et al. PLoS One
- Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
- (2012) Y. H. Chanthery et al. Science Translational Medicine
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Depletion of CD25+ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma
- (2011) W. Jing et al. BLOOD
- Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
- (2011) O. M. Pello et al. BLOOD
- Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling
- (2011) Ming Ma et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor
- (2011) S. Kumar et al. CLINICAL CANCER RESEARCH
- Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
- (2011) Madhu Gowda et al. Journal of Translational Medicine
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma
- (2011) Shakeel Modak et al. PEDIATRIC BLOOD & CANCER
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Matrix Metalloproteinase-9 and Cell Division in Neuroblastoma Cells and Bone Marrow Macrophages
- (2010) M. Gloria Sans-Fons et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity
- (2010) Pascal-David Johann et al. BMC CANCER
- FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
- (2010) Pauline Andreu et al. CANCER CELL
- The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention
- (2010) Susan K. Peirce et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model
- (2010) Yuan Wen et al. CANCER SCIENCE
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
- (2010) Ilia N. Buhtoiarov et al. IMMUNOLOGY
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
- (2010) André Oberthuer et al. JOURNAL OF CLINICAL ONCOLOGY
- The sequence of drug administration influences the antitumor effects of bevacizumab and cyclophosphamide in a neuroblastoma model
- (2010) Zijun Zhen et al. MEDICAL ONCOLOGY
- Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression
- (2010) Wilbur A Lam et al. Molecular Cancer
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of cancer invasiveness by the physical extracellular matrix environment
- (2010) Aron Parekh et al. Cell Adhesion & Migration
- Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
- (2009) W. Jing et al. BLOOD
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- A Stiff Blow from the Stroma: Collagen Crosslinking Drives Tumor Progression
- (2009) Mei Rosa Ng et al. CANCER CELL
- HIF-1 and HIF-2 Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1 Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization
- (2009) R. Noguera et al. CLINICAL CANCER RESEARCH
- Cancer-associated fibroblasts and tumor growth – bystanders turning into key players
- (2009) Arne Östman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFα
- (2009) Enrica Balza et al. INTERNATIONAL JOURNAL OF CANCER
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular endothelial growth factor in children with neuroblastoma: a retrospective analysis
- (2009) Gordana Jakovljević et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors
- (2009) Rana Zeine et al. MODERN PATHOLOGY
- CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation
- (2009) Alex J Carlisle et al. Molecular Cancer
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
- (2009) Debbie Liao et al. PLoS One
- HIF-2 maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
- (2009) A. Pietras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-Inducible Factor-2 Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer
- (2008) K. Helczynska et al. CANCER RESEARCH
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Vascular endothelial growth factor expression is closely related to irinotecan-mediated inhibition of tumor growth and angiogenesis in neuroblastoma xenografts
- (2008) Setsuko Kaneko et al. CANCER SCIENCE
- Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma
- (2008) I. Y. Cheung et al. CLINICAL CANCER RESEARCH
- Angiogenesis as a target in neuroblastoma
- (2008) Jochen Rössler et al. EUROPEAN JOURNAL OF CANCER
- Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study
- (2008) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma
- (2008) J Kang et al. ONCOGENE
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
- (2008) E. Fredlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease
- (2008) Thomas L. Sims et al. SURGERY
- MMPs as therapeutic targets—Still a viable option?
- (2007) B FINGLETON SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started